Skip to main content
Standard Chemical & Pharmaceutical Co., Ltd. logo

Standard Chemical & Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,588 across all filing types
Latest filing 2026-05-13 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1720

About Standard Chemical & Pharmaceutical Co., Ltd.

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
115年第1季財務報告書 — 202601_1720_AI1.pdf
Interim / Quarterly Report Classification · 90% confidence The document is a consolidated financial report for the first quarter of the fiscal years 115 and 114, complete with an auditor’s (PwC) review opinion, full interim financial statements (balance sheet, income statement, cash flows, equity changes), and extensive notes. It covers a period shorter than a full fiscal year and contains substantive financial data rather than mere highlights or a publication announcement. This matches the definition of an Interim/Quarterly Report (IR). Q1 115
2026-05-13 Chinese
代子公司「江蘇生達生技醫藥有限公司」公告資金貸與 超限改善計畫執行情形
Regulatory Filings Classification · 85% confidence The document is a regulatory disclosure on the company’s public information platform “公開資訊觀測站,” reporting a subsidiary’s over-limit intercompany fund lending and its corrective plan under clause 51 of securities rules. It does not contain financial statements or represent an investor presentation, earnings release, or full report, but is a compliance announcement. Therefore it falls under the general Regulatory Filings category (RNS).
2026-05-12 Chinese
公告董事會通過115年第一季合併財務報告
Earnings Release Classification · 85% confidence The document is an announcement by the board that the consolidated Q1 financial report has been approved and it provides key financial figures for the quarter (revenues, profits, EPS, assets, liabilities). It does not include full financial statements or detailed MD&A but rather high‐level results. This matches an earnings release rather than a full interim report. Q1 2026
2026-05-12 Chinese
公告本公司股東會決議通過解除董事之競業禁止
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a company disclosure announcing the shareholders’ meeting resolution (with vote results) to lift a director’s non-competition restriction. It clearly states the shareholder vote result and approval percentage, which fits “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-12 Chinese
公告本公司115年度股東常會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is a public announcement from the company’s annual general meeting on the Market Observation Post System, listing the important resolutions and voting outcomes (e.g., profit distribution, articles amendments, approval of financial statements, capital increase, etc.). This matches a Declaration of Voting Results & Voting Rights Announcement rather than the meeting materials themselves or a dividend notice. Therefore it is classified as DVA.
2026-05-12 Chinese
公告本公司民國115年第一季財務報告 董事會預計召開日期為115年05月12日
Regulatory Filings
2026-05-04 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.